Developer docs
API playgroundTry for free, no card

Search company profiles

RenFuel

Full company profile

uuid0003wva

Namestring
RenFuel
Legal namestring
RenFuel K2B AB
Websiteurl
renfuel.se
Company typeenum
Private
Founded yearint
2012
Descriptiontext

RenFuel K2B AB was a Swedish privately-held biotechnology company operating in the bioenergy and green chemistry sector. Founded in 2012 and headquartered in Stockholm, the company developed a patented catalytic esterification process for refining biointermediates from biomass, with its principal product output being lignin esters suitable for downstream biofuel and biochemical applications. The technology addressed the conversion of organic biomass materials into higher-value bio-based chemical intermediates, serving bioenergy and biochemical producers as its primary use-case customer segment.

The company's business model centered on monetizing its proprietary catalytic esterification IP rather than scaling direct commercial production. RenFuel was sustained primarily by corporate funding from Bioleum Corporation (a strategic investee of Comstock Inc.), which committed approximately $1 million per year under a 2024 agreement and had previously participated in a $350,000 round in April 2024. Pricing, GTM motion, and named end customers were not publicly disclosed, and the headcount range of 1-10 employees indicates a research- and IP-focused organization rather than a commercial-scale operation.

On December 3, 2025, Bioleum Corporation acquired substantially all of RenFuel's patents and intellectual property assets for $18.1 million (comprising $12.5M in Bioleum stock, $2.5M in warrants, $2.6M in debt forgiveness, and $500K in cash), plus a contingent earn-out of 3% of revenues from lignin ester production capped at $11.9 million. The transaction terminated Bioleum's pre-existing annual funding commitment and effectively absorbed RenFuel's technology into Bioleum, leaving RenFuel K2B AB no longer operating as an independent commercial entity.

Short descriptiontext

RenFuel K2B AB was a Swedish bioenergy company that developed a patented catalytic esterification process for converting biomass into lignin esters and biointermediates, serving bioenergy and biochemical producers. The company was acquired by Bioleum Corporation in December 2025.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersStockholm, Sweden
HQ citystring
Stockholm
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
lignin ester production, biomass conversion technology, catalytic esterification process, biointermediate refining, forest biomass chemistry
Industry3 codes
PRIMARYEUAAAHAJ
Biofuel Co-products & Byproduct Processing (DDGS, Glycerin, CO2, Lignin)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biofuels Production (Ethanol, Biodiesel, Renewable Diesel, SAF)
SECONDARYIMAMALAA
Cellulosic Biofuels & Renewable Fuels (2G ethanol, SAF intermediates)
SECONDARYEUAAAIAA
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code2 codes
  • Other Basic Organic Chemical Manufacturing32519
  • Chemical Manufacturing325
SIC code1 code
  • Industrial Organic Chemicals2860
Product category
Biointermediates & Lignin Esters
No data
Cost components4 values
Personnel, Technology or R&D, Operations, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

RenFuel K2B AB developed and held a patented catalytic esterification process for converting biomass into biointermediates and lignin esters. The technology enables the transformation of forest-derived biomass materials into refined bio-based chemical intermediates used in energy and biochemical production. Substantially all of RenFuel's patents and intellectual property assets were acquired by Bioleum Corporation in December 2025 for $18.1 million, with a contingent 3% revenue royalty on lignin ester production capped at $11.9 million.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 3% revenue royalty on lignin ester production with $11.9 million cap from IP licensing arrangement
Product overview1 text field

RenFuel K2B AB was a biotechnology company specializing in biointermediates and biomass conversion technology. Its core product was the patented catalytic esterification process for refining biointermediates. As of December 2025, substantially all patents and intellectual property assets of RenFuel were acquired by Bioleum Corporation for $18.1 million, including the catalytic esterification process technology.

Product and service1 record
1Catalytic Esterification Process
CategoryBiomass Conversion Process Technology
Description

Patented catalytic esterification process for refining biointermediates from biomass, enabling production of lignin esters for industrial bioenergy and biochemical applications. Targeted at bioenergy and biochemical producers seeking scalable conversion of renewable biomass feedstocks into bio-based chemical intermediates.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Norwegian biorefinery operating one of the world's largest commercial lignin production facilities (BioLift lignin products). Borregaard is a direct comparator because it operates at the intersection of forest biomass and bio-based chemicals, the same end markets RenFuel's catalytic esterification targets.

TypeEmerging player
Description

Swiss startup developing chemistry to convert biomass — including lignin — into renewable chemical building blocks. Bloom is comparable as a similarly staged European bio-based chemicals company tackling lignin valorization with proprietary chemical conversion technology.

TypeEmerging player
Description

Dutch startup developing lignin-to-crude-oil (LCO) technology for renewable fuels and chemicals. Vertoro is comparable as a European emerging player converting lignin into liquid bio-based products, similar in product family to RenFuel's lignin esters.

TypeEmerging player
Description

Industrial biotechnology company producing enzymes and biocatalysts for biomass conversion, including lignin valorization. MetGen is comparable as a similarly staged European industrial biotech developing process technology for converting lignocellulosic feedstocks into chemicals.

TypeEmerging player
Description

US-based developer of supercritical water-based cellulosic biomass fractionation technology producing sugars and lignin streams for biofuels and chemicals. Renmatix is comparable as a similarly staged technology company focused on lignocellulosic biomass conversion into biointermediates.

TypeBroad incumbent
Description

Clariant's sunliquid technology is a commercial-stage cellulosic ethanol process using proprietary enzymatic conversion of lignocellulosic biomass. Comparable as a broad incumbent with proprietary catalytic/biological process technology addressing the same biomass-to-biofuels-and-chemicals opportunity.

TypeBroad incumbent
Description

Finnish forest industry major operating commercial-scale production of advanced biofuels from crude tall oil and wood-based residues. Comparable as a Nordic incumbent leveraging forest biomass to produce renewable fuels, the same downstream category RenFuel's lignin ester technology targets.

TypeBroad incumbent
Description

Major Nordic pulp and paper company with growing biomaterials and lignin-based product lines (e.g., Lineo lignin). Stora Enso is comparable as an integrated forest-industry incumbent extracting value from lignin, the same feedstock RenFuel's catalytic esterification technology processes.

TypeEmerging player
Description

US-based developer of catalytic processes (BioBTX) to convert non-food biomass into aromatic chemicals, particularly BTX. Anellotech is comparable as a similarly staged technology developer using catalytic conversion of biomass into bio-based chemical building blocks.

TypeOthers
Description

US-based strategic investee of Comstock Inc. that acquired substantially all RenFuel IP in December 2025. Bioleum is the immediate counterparty and commercialization vehicle for RenFuel's technology, with shared strategic alignment in biomass-to-fuels-and-chemicals.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RenFuel

Biointermediates & Lignin Estersrenfuel.se

RenFuel K2B AB was a Swedish bioenergy company that developed a patented catalytic esterification process for converting biomass into lignin esters and biointermediates, serving bioenergy and biochemical producers. The company was acquired by Bioleum Corporation in December 2025.

What RenFuel does

RenFuel K2B AB was a Swedish privately-held biotechnology company operating in the bioenergy and green chemistry sector. Founded in 2012 and headquartered in Stockholm, the company developed a patented catalytic esterification process for refining biointermediates from biomass, with its principal product output being lignin esters suitable for downstream biofuel and biochemical applications. The technology addressed the conversion of organic biomass materials into higher-value bio-based chemical intermediates, serving bioenergy and biochemical producers as its primary use-case customer segment.

The company's business model centered on monetizing its proprietary catalytic esterification IP rather than scaling direct commercial production. RenFuel was sustained primarily by corporate funding from Bioleum Corporation (a strategic investee of Comstock Inc.), which committed approximately $1 million per year under a 2024 agreement and had previously participated in a $350,000 round in April 2024. Pricing, GTM motion, and named end customers were not publicly disclosed, and the headcount range of 1-10 employees indicates a research- and IP-focused organization rather than a commercial-scale operation.

On December 3, 2025, Bioleum Corporation acquired substantially all of RenFuel's patents and intellectual property assets for $18.1 million (comprising $12.5M in Bioleum stock, $2.5M in warrants, $2.6M in debt forgiveness, and $500K in cash), plus a contingent earn-out of 3% of revenues from lignin ester production capped at $11.9 million. The transaction terminated Bioleum's pre-existing annual funding commitment and effectively absorbed RenFuel's technology into Bioleum, leaving RenFuel K2B AB no longer operating as an independent commercial entity.

RenFuel firmographics

Firmographics
Name
RenFuel
Legal name
RenFuel K2B AB
Website
https://renfuel.se
Company type
Private
Founded year
2012
Operating status
Acquired
Headcount range
1–10 employees
Short description
RenFuel K2B AB was a Swedish bioenergy company that developed a patented catalytic esterification process for converting biomass into lignin esters and biointermediates, serving bioenergy and biochemical producers. The company was acquired by Bioleum Corporation in December 2025.
Ownership category
akta.pro rank

RenFuel industry classification

Industry
Product category
Biointermediates & Lignin Esters
NAICS
Other Basic Organic Chemical Manufacturing (32519), Chemical Manufacturing (325)
SIC
Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYEUAAAHAJ
Biofuel Co-products & Byproduct Processing (DDGS, Glycerin, CO2, Lignin)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biofuels Production (Ethanol, Biodiesel, Renewable Diesel, SAF)
SECONDARYIMAMALAA
Cellulosic Biofuels & Renewable Fuels (2G ethanol, SAF intermediates)
SECONDARYEUAAAIAA
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Lignin ester production
  • Biomass conversion technology
  • Catalytic esterification process
  • Biointermediate refining
  • Forest biomass chemistry

Where RenFuel is headquartered

Location

Headquarters

HQ city
Stockholm
HQ country
Sweden
HQ region
Europe

Markets served

RenFuel business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Others

RenFuel product offering

Product offering

Core offering

RenFuel K2B AB developed and held a patented catalytic esterification process for converting biomass into biointermediates and lignin esters. The technology enables the transformation of forest-derived biomass materials into refined bio-based chemical intermediates used in energy and biochemical production. Substantially all of RenFuel's patents and intellectual property assets were acquired by Bioleum Corporation in December 2025 for $18.1 million, with a contingent 3% revenue royalty on lignin ester production capped at $11.9 million.

Product overview

RenFuel K2B AB was a biotechnology company specializing in biointermediates and biomass conversion technology. Its core product was the patented catalytic esterification process for refining biointermediates. As of December 2025, substantially all patents and intellectual property assets of RenFuel were acquired by Bioleum Corporation for $18.1 million, including the catalytic esterification process technology.

Differentiator

Problem solved

Functional benefit

Products and services

  • Catalytic Esterification Process Patented catalytic esterification process for refining biointermediates from biomass, enabling production of lignin esters for industrial bioenergy and biochemical applications. Targeted at bioenergy and biochemical producers seeking scalable conversion of renewable biomass feedstocks into bio-based chemical intermediates.

Quantifiable outcome

  • 3% revenue royalty on lignin ester production with $11.9 million cap from IP licensing arrangement

Companies that use RenFuel

Customer profile

Segments1 record

Ideal customer profiles1 record

RenFuel technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

RenFuel partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights2 records

RenFuel competitors and assessment

Company assessment

Broad incumbents

  • Borregaard: Norwegian biorefinery operating one of the world's largest commercial lignin production facilities (BioLift lignin products). Borregaard is a direct comparator because it operates at the intersection of forest biomass and bio-based chemicals, the same end markets RenFuel's catalytic esterification targets.
  • Clariant (sunliquid): Clariant's sunliquid technology is a commercial-stage cellulosic ethanol process using proprietary enzymatic conversion of lignocellulosic biomass. Comparable as a broad incumbent with proprietary catalytic/biological process technology addressing the same biomass-to-biofuels-and-chemicals opportunity.
  • UPM Biofuels: Finnish forest industry major operating commercial-scale production of advanced biofuels from crude tall oil and wood-based residues. Comparable as a Nordic incumbent leveraging forest biomass to produce renewable fuels, the same downstream category RenFuel's lignin ester technology targets.
  • Stora Enso (Biomaterials division): Major Nordic pulp and paper company with growing biomaterials and lignin-based product lines (e.g., Lineo lignin). Stora Enso is comparable as an integrated forest-industry incumbent extracting value from lignin, the same feedstock RenFuel's catalytic esterification technology processes.

Emerging players

  • Bloom Biorenewables: Swiss startup developing chemistry to convert biomass — including lignin — into renewable chemical building blocks. Bloom is comparable as a similarly staged European bio-based chemicals company tackling lignin valorization with proprietary chemical conversion technology.
  • Vertoro: Dutch startup developing lignin-to-crude-oil (LCO) technology for renewable fuels and chemicals. Vertoro is comparable as a European emerging player converting lignin into liquid bio-based products, similar in product family to RenFuel's lignin esters.
  • MetGen: Industrial biotechnology company producing enzymes and biocatalysts for biomass conversion, including lignin valorization. MetGen is comparable as a similarly staged European industrial biotech developing process technology for converting lignocellulosic feedstocks into chemicals.
  • Renmatix: US-based developer of supercritical water-based cellulosic biomass fractionation technology producing sugars and lignin streams for biofuels and chemicals. Renmatix is comparable as a similarly staged technology company focused on lignocellulosic biomass conversion into biointermediates.
  • Anellotech: US-based developer of catalytic processes (BioBTX) to convert non-food biomass into aromatic chemicals, particularly BTX. Anellotech is comparable as a similarly staged technology developer using catalytic conversion of biomass into bio-based chemical building blocks.

Others

  • Bioleum Corporation: US-based strategic investee of Comstock Inc. that acquired substantially all RenFuel IP in December 2025. Bioleum is the immediate counterparty and commercialization vehicle for RenFuel's technology, with shared strategic alignment in biomass-to-fuels-and-chemicals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

RenFuel financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RenFuel leadership team

Management profile

Number of profiles

RenFuel funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RenFuel M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RenFuel

What does RenFuel do?

RenFuel K2B AB developed and held a patented catalytic esterification process for converting biomass into biointermediates and lignin esters. The technology enables the transformation of forest-derived biomass materials into refined bio-based chemical intermediates used in energy and biochemical production. Substantially all of RenFuel's patents and intellectual property assets were acquired by Bioleum Corporation in December 2025 for $18.1 million, with a contingent 3% revenue royalty on lignin ester production capped at $11.9 million.

Is RenFuel a public or private company?

RenFuel is a private company. It is classified as corporate owned and is currently acquired.

When was RenFuel founded?

RenFuel was founded in 2012. It employs 1 to 10 people.

Where is RenFuel based?

RenFuel is headquartered in Stockholm, Sweden, in the Europe region.

Who are RenFuel's main competitors?

Broad incumbents on record are Borregaard, Clariant (sunliquid), UPM Biofuels and Stora Enso (Biomaterials division). Emerging players are Bloom Biorenewables, Vertoro, MetGen, Renmatix and Anellotech. Bioleum Corporation is listed as an others.

Does RenFuel have an API?

No public API is recorded for RenFuel.

What industry is RenFuel in?

RenFuel's product category is Biointermediates & Lignin Esters. Its primary akta.pro industry code is EUAAAHAJ, Biofuel Co-products & Byproduct Processing (DDGS, Glycerin, CO2, Lignin), with a secondary code of IMAMALAA, Cellulosic Biofuels & Renewable Fuels (2G ethanol, SAF intermediates). Its NAICS code is 32519 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comBioleum acquires RenFuel’s patents for $18.1 million By Investing.comBioleum Corporation acquired substantially all patents and intellectual property assets from RenFuel K2B AB for $18.1 million in a combination of stock, warrants, debt forgiveness, and cash. The transaction grants Bioleum access to RenFuel's patented catalytic esterification process to refine its biointermediates while granting RenFuel an exclusive license for biomaterials applications with a 3% royalty. As part of the agreement, Bioleum entered into a development services agreement utilizing RenFuel's laboratory and pilot systems located in Upsala, Sweden.Investing.comBioleum acquires RenFuel’s patents for $18.1 million By Investing.comBioleum Corporation has acquired substantially all patents and intellectual property assets from RenFuel K2B AB for a total value of $18.1 million, structured through stock, warrants, debt forgiveness, and cash. The transaction provides Bioleum with access to RenFuel’s patented catalytic esterification process to refine its biointermediates, while granting RenFuel an exclusive license for biomaterials applications subject to royalties. Bioleum also entered into a development services agreement to utilize RenFuel's laboratory and pilot systems located in Sweden.Stock TitanBioleum acquires RenFuel IP in $18.1M biofuel tech dealBioleum Corporation acquired substantially all of the intellectual property assets, including patents for a catalytic esterification process, from RenFuel K2B AB for a total consideration of $18.1 million. The transaction involves a mix of stock, warrants, debt forgiveness, and cash, along with a contingent earn-out based on future revenues. Bioleum also granted RenFuel an exclusive license for biomaterials applications and entered into a development services agreement to continue technology work.Investing.comBioleum acquires RenFuel’s patents for $18.1 million By Investing.comComstock Inc.'s strategic investee Bioleum Corporation has acquired substantially all patents and intellectual property assets of RenFuel K2B AB for $18.1 million in a deal comprising $12.5 million in Bioleum stock, $2.5 million in warrants, $2.6 million in debt forgiveness, and $500,000 in cash. The acquisition includes a contingent earn-out of 3% of revenues from lignin ester production, capped at $11.9 million, giving Bioleum access to RenFuel's patented catalytic esterification process for refining biointermediates. The transaction terminates Bioleum's pre-existing commitment to fund approximately $1 million per year to RenFuel under a previous 2024 agreement.GlobeNewswireComstock Completes RenFuel InvestmentComstock Inc. announced an investment of up to $3 million over three years in RenFuel K2B AB to support joint development of renewable fuel technologies and a 100,000 metric ton per year biorefinery in Sweden. The investment is via 7% senior secured convertible notes, with $350,000 already invested. The partnership aims to accelerate commercialization of Comstock's Bioleum and SAF production.Business InsiderComstock Completes RenFuel InvestmentComstock Inc. announced an investment of up to $3 million over three years in RenFuel K2B AB, to support joint development of renewable fuel technologies and a 100,000 metric ton per year biorefinery in Sweden. The investment is in 7% senior secured convertible notes, with $350,000 already invested.GlobeNewswireComstock Completes RenFuel InvestmentComstock Inc. announced an investment of up to $3 million over three years in RenFuel K2B AB to support joint development of renewable fuel technologies and a 100,000 metric ton per year biorefinery in Sweden. The investment is via 7% senior secured convertible notes, with $350,000 already invested. The partnership aims to accelerate commercialization of Bioleum and SAF production.